Aditxt announced a transaction to separate its subsidiary Ignite Proteomics into an independent public company named Ignite Proteomics Inc., while Aditxt remains listed on Nasdaq. Ignite focuses on precision oncology, particularly breast cancer, and aims to expand its tumor type coverage. The deal is intended to unlock value for Ignite and provide it with better access to growth capital for commercialization and clinical efforts. Aditxt shares fell about 28% in premarket trading amid weak market sentiment for volatile microcaps, with the stock deeply oversold technically. The transaction awaits shareholder and regulatory approvals before completion.
Kuva Labs has initiated a tender offer to buy all outstanding shares of Lisata Therapeutics at $4.00 per share in cash, with an additional contingent value right (CVR) offering up to $3.00 per share if certain clinical milestones are met. The Lisata ...
FirstService Corporation announced that its subsidiary, Roofing Corp of America (RCA), has acquired Schefers Roofing, a commercial roofing contractor based in Kansas City. This acquisition expands RCA's geographic footprint into the Kansas City marke...
Figure Technology Solutions announced it will acquire Kiavi, an AI-driven lending platform for residential real estate investors, in a $717 million deal. This acquisition will integrate Kiavi's $7 billion annual loan volume into Figure's blockchain-n...
Amazon has expanded its less-than-truckload (LTL) freight service across the U.S., enabling businesses of all sizes to ship palletized freight beyond Amazon's network. This move supports Amazon's broader strategy to grow its third-party logistics bus...
Tecnoglass Inc., a leading manufacturer of high-end aluminum and vinyl windows and architectural glass, announced a quarterly dividend of $0.15 per share for the second quarter of 2026. Shareholders recorded by June 30, 2026, will receive the dividen...
